Press release
Erectile Dysfunction Drugs Market Size to Reach $2.63 Billion by 2025 | Industry Players: Bayer AG, Pfizer, Eli Lilly & Co., Vivus, Inc., S.K. Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd, Meda Pharmaceuticals, Apricus Biosciences, and others
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025. Impotence, also known as erectile dysfunction is the condition of sexual dysfunction where, during the sexual intercourse, men cannot maintain the erection. According to World Health Organization statement, for the emotional, physical and wellbeing of the individual, and to the economic and social development of countries and communities, sexual health is a fundamental thing. Erectile dysfunction affects the quality of life for both partners and patients and is connected with relationship difficulties.Request for a sample of this research report @https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request-for-sample?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika22_April_erectile-dysfunction-drugs_smpl&utm_content=Content
Erectile dysfunction is generally an age-related condition but can also be triggered by psychological factors. Cardiovascular diseases such as high blood pressure, clogged arteries etc., diabetes, hormonal insufficiency, chronic kidney disease, multiple sclerosis, injury to the penis, bladder, and pelvis, and neurological issues are the common factor which can cause erectile dysfunction. Moreover, sedentary lifestyle, smoking, excessive alcohol intake, obesity and consumption of drugs such as, antihypertensive drugs, antidepressant, recreational drugs, and psychotropic drugs are some other factors which are significantly contributing towards erectile dysfunction. Exercise, pharmacotherapy, well balanced and maintain lifestyle, penis implants, erection devices, and injections into penis are current treatment available to cure erectile dysfunction. Currently, oral PDE5 (phosphodiesterase type 5 inhibitors) is the first line drug therapy prescribed by physicians for erectile dysfunction.
The availability of oral drugs globally, and rising awareness about erectile dysfunction and sexual diseases is resulting in significant adoption of treatment globally. Moreover, rising number of referrals to secondary care and primary care consultations is expected to propel the growth of erectile dysfunctions drugs market over the forecast period. The increasing elderly population and high rate of chronic diseases such as kidney failure, diabetes, hypertension, hormonal imbalance, and neurological disorders are increasing demand for erectile dysfunction drugs globally.
Make Inquiry about this report @https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika22_April_erectile-dysfunction-drugs_inq&utm_content=Content
The global erectile dysfunction drugs market is segmented on the basis of drug type, dosage form, end user, and geographically. On the basis of drug type, the global erectile dysfunction market is further segmented into Testosterone, Phosphodiestarse – 5 Inhibitors (PDE5I), Alprostadil, and others. Testosterone is hormone. The lack of testosterone hormone cause impotence or erectile dysfunction, and in such conditions, testosterone hormones are prescribed to the patient to balance the hormone in the body. The Phosphodiestarse – 5 Inhibitors is the drug used to control or block the degenerative action of c-GMP specific phosphodiesterase type 5 (PDE5) on cyclic GMP. The Sildenafil, Vardenafil, Tadalafil, Avanafil, Udenafil are the few examples of Phosphodiestarse – 5 Inhibitors. The Phosphodiestarse – 5 Inhibitors drugs are most commonly prescribed drugs to treat erectile dysfunction and hence accounted major share in global erectile dysfunction drugs market.
The high effectiveness and efficacy of Phosphodiestarse – 5 Inhibitors are the major factors contributing towards the large share in the global erectile dysfunction market. The introduction of long effective pills such as Levitra (vardenafil) and Cialis (tadalafil) are effective for 36 hours and hence they are also know as weekend pill. Moreover, the increasing research and development and various drugs for erectile dysfunction are in various stages of pipeline. The introduction of such blockbuster drugs in the market over the forecast period is expected to propel the growth of erectile dysfunction market globally.
By dosage form, the global erectile dysfunction drugs market is further sub segmented into topical, oral, injections and others. The oral segment accounted major share in global erectile dysfunction drugs market. The oral drugs are more convenient to handle the dose, and hence it is highly preferable dosage form. The injections segment is expected to grow at high CAGR over the forecast period.
Browse for full research summary: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika22_April_erectile-dysfunction-drugs_RD&utm_content=Content
Erectile Dysfunction Drugs Market Size and Forecast by Product
Key findings
o Viagra (Sildenafil citrate)
o Cialis (tadalafil)
o Levitra/Staxyn (vardenafil)
o Stendra/Spedra (avanafil)
o Zydena (udenafil)
o Vitaros (Alprostadil Cream)
o Others
Erectile Dysfunction Drugs Market Size and Forecast by Component Type
Key findings
o Testosterone
o Phosphodiestarse - 5 Inhibitors (PDE5I)
o Alprostadil
o Others
Erectile Dysfunction Drugs Market Size and Forecast by Dosage Form
Key findings
o Oral
o Topical
o Injections
o Others
Erectile Dysfunction Drugs Market Size and Forecast by Distribution Channel
Key findings
o Hospital Pharmacy
o Retail Pharmacy
o Online Pharmacy
Erectile Dysfunction Drugs Market Size and Forecast by Regions
Key findings
o North America
U.S.
Canada
Mexico
o Europe
Germany
UK
o Asia Pacific
China
India
Japan
o Latin America
Brazil
o Middle East & Africa
Check for discount: https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/request-for-discount-pricing?utm_source=openpr.com&utm_medium=Referral&utm_campaign=Monika22_April_erectile-dysfunction-drugs_dsc&utm_content=Content
About Polaris Market Research
Polaris Market Research is a global market research and consulting company. We provide unmatched quality of offerings to our clients present globally. The company specializes in providing exceptional market intelligence and in-depth business research services for our clientele spread across different enterprises. We at Polaris are obliged to serve our diverse customer base present across the industries of healthcare, technology, semi-conductors and chemicals among various other industries present around the world. We strive to provide our customers with updated information on innovative technologies, high growth markets, emerging business environments and latest business-centric applications, thereby helping them always to make informed decisions and leverage new opportunities.
Contact us-
Mr. Rohit
Corporate Sales, USA
Polaris Market Research
Phone: 1-646-568-9980
Email: sales@polarismarketresearch.com
Web: www.polarismarketresearch.com
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Erectile Dysfunction Drugs Market Size to Reach $2.63 Billion by 2025 | Industry Players: Bayer AG, Pfizer, Eli Lilly & Co., Vivus, Inc., S.K. Chemicals Co. Ltd., Dong-A Pharmaceutical Co. Ltd, Meda Pharmaceuticals, Apricus Biosciences, and others here
News-ID: 1712309 • Views: …
More Releases from Polaris Market Research & Consulting

Granite Market Projected to Reach USD 6.63 Billion by 2034, Growing at a CAGR of …
Polaris Market Research has released new insights into the Granite market, highlighting key developments, evolving trends, and growth prospects across major regions and segments. The report delivers an in-depth analysis of market dynamics, competitive shifts, and strategic outlooks to support informed decision-making for businesses and investors.
Market at a Glance
In 2024, the market was valued at USD 3.99 billion and is anticipated to grow to USD 6.63 Billion by 2034. It…

Molecular Diagnostics for Sexually Transmitted Diseases Market to Reach USD 7.85 …
Polaris Market Research announces the release of its latest study on the Molecular Diagnostics For Sexually Transmitted Diseases market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 3.82 billion in 2024 and is expected to…

Higher Alpha Olefins Market Projected to Hit USD 20.01 Billion by 2034, Expandin …
Polaris Market Research announces the release of its latest study on the Higher Alpha Olefins market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 10.39 billion in 2024 and is expected to reach 20.01 billion…

Direct Oral Anticoagulants (DOACs) Device Market to Reach USD 64.83 Billion by 2 …
Polaris Market Research announces the release of its latest study on the Direct Oral Anticoagulants (DOACs) Device market. It offers comprehensive insights into all the key market aspects, including industry trends, market dynamics, competitive landscape, and strategic developments. The report is designed to help stakeholders make strategic decisions in the rapidly evolving market landscape.
According to the findings, the market stood at 31.67 billion in 2024 and is expected to reach…
More Releases for Erectile
Erectile Dysfunction Drugs Market Beyond the Bedroom: The Impact of Erectile Dys …
Erectile Dysfunction Drugs Market to reach over USD XX billion by the year 2031 - Exclusive Report by InsightAce Analytic
InsightAce Analytic Pvt. Ltd. announces the release of a market assessment report on the "Global Erectile Dysfunction Drugs Market Size, Share & Trends Analysis Report By Drug (Avanafil (Stendra), Muse Suppository (Alprostadil), Sildenafil (Viagra)), Mode of Administration (Injections, Oral, Topical), Distribution Channel (hospital pharmacies, online pharmacies, and retail pharmacies), Region, Market…
Global Erectile Dysfunction Devices Market Size & Trends
According to a new market research report published by Global Market Estimates, the Global Erectile Dysfunction Devices Market is projected to grow at a CAGR of 9.6% from 2023 to 2028.
The market is driven by the increasing prevalence of erectile dysfunction amongst young men, advancements in medical technology, growing awareness and acceptance, the aging population, and strategic collaborations.
Browse 147 Market Data Tables and 115 Figures spread through 163 Pages…
Erectile dysfunction drugs market to Surpass erectile dysfunction drugs market | …
Global Erectile Dysfunction Drugs Market size was valued at USD 2130 million in 2021 and is projected to reach USD 3250 million by 2028, growing at a CAGR of 5.4% from 2021 to 2028 according to a new report by Intellectual Market Insights Research.
Get Sample Report:https://www.intellectualmarketinsights.com/download-sample/IMI-003946
Scope of Erectile Dysfunction Drugs Market Report:
A recent market research report added to repository of Intellectual Market Insights Research is an in-depth analysis of Global…
Global Erectile Dysfunction Devices Market Report
As per GME studies, on the Global Erectile Dysfunction Devices Market, it is analyzed that the market will grow at a CAGR of 6.5%. Erectile dysfunction incidence increases with growing age, about 5-10% of men under 40 years are the possible suspects for the dysfunctionality. This is projected to drive the ED device market in the coming years also. Raising the aforementioned disease prevalence and the growing percentage of tobacco…
Erectile Dysfunction Drugs Market Size, Erectile Dysfunction Drugsmarket Share, …
According to a new study published by Polaris Market Research the global erectile dysfunction drugs market is anticipated to reach USD 2.63 billion by 2025.
Request for Sample of This Research Report @ https://bit.ly/2NXzatD
Top Key Players:-
Bayer AG
Pfizer
Eli Lilly & Co.
Vivus, Inc.
S.K. Chemicals Co. Ltd.
Dong-A Pharmaceutical Co. Ltd
Meda Pharmaceuticals
Apricus Biosciences
Make an inquiry before buying this report @ https://www.polarismarketresearch.com/industry-analysis/erectile-dysfunction-drugs-market/inquire-before-buying
According to a new study published by Polaris Market Research the global erectile dysfunction…
Erectile Dysfunction Market Industry Forecast till 2024
Erectile dysfunction is known as the medical condition of penis, a recurrent inability of a man to reach and/or to maintain a penile erection sufficient for/during sexual activities. It is most probably an age-related factor, progressive condition, affecting some level of disorder (mild, moderate or severe) in about 50% of men aged 40-70 years, and with the increase in the age, severity of erectile dysfunction also increase with a…